Written Question·Department of Health and Social Care·UIN 26253

Pancreatic Enzyme Replacement Therapy: Shortages

Tabled: 23 January 2025

Answered: 30 January 2025

Question

David Chadwick

Liberal Democrat — Brecon, Radnor and Cwm Tawe

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential economic impact of seeking unlicensed products as an alternative to Creon to mitigate ongoing pancreatic enzyme replacement therapy shortages on pharmac

Answer

Karin Smyth

There has been no assessment on the potential economic impact of seeking unlicensed products as an alternative to Creon.The Department is continuing to engage with suppliers of pancreatic enzyme replacement therapy (PERT) and special importers of unlicens...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 26253) →